Literature DB >> 11530806

A variant form of myelodysplastic syndrome with Ph- minor-BCR/ABL transcript.

T Wakayama1, Y Maniwa, H Ago, N Kakazu, T Abe.   

Abstract

This study concerns a patient with minor (m)-BCR/ABL transcript-positive and Philadelphia (Ph) chromosome-negative myelodysplastic syndrome (MDS). The patient was a 78-year-old man whose condition was diagnosed as refractory anemia with excess of blasts in transformation. Molecular genetic studies, using reverse transcriptase polymerase chain reaction analysis detected m-BCR/ABL messenger RNA. We used spectral karyotyping to analyze metaphase cells but could not detect a Ph chromosome. Fluorescence in situ hybridization, however, revealed fusion signals of BCR and ABL probes on an apparently normal chromosome 22.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530806     DOI: 10.1007/BF02982550

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  14 in total

Review 1.  The biology of chronic myeloid leukemia.

Authors:  S Faderl; M Talpaz; Z Estrov; S O'Brien; R Kurzrock; H M Kantarjian
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

Review 2.  p190bcr/abl rearrangement in myelodysplastic syndromes: two reports and review of the literature.

Authors:  J F Lesesve; X Troussard; C Bastard; J P Hurst; D Nouet; M P Callat; B Lenormand; H Piguet; G Flandrin; E Macintyre
Journal:  Br J Haematol       Date:  1996-11       Impact factor: 6.998

3.  Late-appearing Philadelphia chromosome in a patient with acute nonlymphocytic leukaemia derived from myelodysplastic syndrome: detection of P210- and P190-type bcr/abl fusion gene transcripts at the leukaemic stage.

Authors:  M Katsuno; S Yamashita; S Sadamura; T Umemura; J Hirata; J Nishimura; H Nawata
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

4.  Multicolor spectral karyotyping of human chromosomes.

Authors:  E Schröck; S du Manoir; T Veldman; B Schoell; J Wienberg; M A Ferguson-Smith; Y Ning; D H Ledbetter; I Bar-Am; D Soenksen; Y Garini; T Ried
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

Review 5.  Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature.

Authors:  G Verhoef; P Meeus; M Stul; C Mecucci; J J Cassiman; H Van Den Berghe; M Boogaerts
Journal:  Cancer Genet Cytogenet       Date:  1992-04

6.  Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.

Authors:  N Kakazu; M Taniwaki; S Horiike; K Nishida; T Tatekawa; M Nagai; T Takahashi; T Akaogi; J Inazawa; M Ohki; T Abe
Journal:  Genes Chromosomes Cancer       Date:  1999-12       Impact factor: 5.006

Review 7.  Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?

Authors:  G E Verhoef; H Demuynck; P Zachee; M A Boogaerts
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

8.  Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia.

Authors:  J Inazawa; H Nishigaki; H Takahira; J Nishimura; S Horiike; M Taniwaki; S Misawa; T Abe
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

9.  The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H Gralnick; C Sultan; C Cox
Journal:  Br J Haematol       Date:  1994-08       Impact factor: 6.998

10.  Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript.

Authors:  T Kohno; T Amenomori; S Atogami; I Sasagawa; H Nakamura; K Kuriyama; M Tomonaga
Journal:  Br J Haematol       Date:  1996-05       Impact factor: 6.998

View more
  2 in total

1.  De Novo Philadelphia Chromosome (BCR/ABL1) Positive Myelodysplastic Syndrome: Is it a Distinct Molecular and Clinical Entity?

Authors:  Darko Katalinic
Journal:  Indian J Hematol Blood Transfus       Date:  2017-08-07       Impact factor: 0.900

2.  Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia.

Authors:  Benjamin Podvin; Hélène Guermouche; Pauline Roynard; Laure Goursaud; Céline Berthon; Mahdi Ouafi; Elise Fourner; Nicolas Duployez; Olivier Nibourel; Catherine Roche-Lestienne
Journal:  Ann Hematol       Date:  2022-05-13       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.